GAMBATO, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.195
AS - Asia 561
EU - Europa 472
SA - Sud America 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.236
Nazione #
US - Stati Uniti d'America 3.189
CN - Cina 280
SG - Singapore 202
IT - Italia 176
DE - Germania 68
FI - Finlandia 68
SE - Svezia 57
VN - Vietnam 53
FR - Francia 36
GB - Regno Unito 35
IN - India 13
IE - Irlanda 10
UA - Ucraina 7
JP - Giappone 6
CA - Canada 5
NL - Olanda 5
BR - Brasile 3
ES - Italia 3
AT - Austria 2
ET - Etiopia 2
PL - Polonia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BZ - Belize 1
EC - Ecuador 1
ID - Indonesia 1
MO - Macao, regione amministrativa speciale della Cina 1
RO - Romania 1
SI - Slovenia 1
Totale 4.236
Città #
Fairfield 509
Chandler 307
Ann Arbor 300
Woodbridge 245
Ashburn 227
Houston 216
Cambridge 184
Seattle 178
Singapore 162
Wilmington 131
Boardman 82
San Diego 77
Beijing 76
Santa Clara 68
Des Moines 67
Medford 57
Princeton 57
Padova 54
Dong Ket 53
Helsinki 44
Roxbury 37
Nanjing 27
Guangzhou 24
Shenyang 16
London 12
Milan 11
Dublin 10
Hebei 10
Falls Church 9
Munich 9
New York 9
Ogden 8
Pune 8
Cagliari 6
Hefei 6
Tianjin 6
Changsha 5
Fuzhou 5
Jinan 5
Nanchang 5
Ningbo 5
Paris 5
Pisa 5
Trieste 5
Vicenza 5
Washington 5
Zhengzhou 5
Chicago 4
Nonantola 4
Phoenix 4
Redwood City 4
Borås 3
Chiswick 3
Dolo 3
Kharkiv 3
Kunming 3
Lappeenranta 3
Lozzo Atestino 3
Naples 3
Nürnberg 3
Palermo 3
Recife 3
Shanghai 3
Verona 3
Addis Ababa 2
Amsterdam 2
Bologna 2
Boston 2
Dallas 2
Frankfurt am Main 2
Fremont 2
Hounslow 2
Ichikawa 2
Kilburn 2
Majadahonda 2
Miyaharachō 2
Prescot 2
Quzhou 2
Rockville 2
Rome 2
Taipei 2
Taizhou 2
Toronto 2
Treviso 2
Trezzo sull'Adda 2
Venice 2
Aachen 1
Baku 1
Belize City 1
Biassono 1
Brussels 1
Bussolengo 1
Calgary 1
Campolongo 1
Charles Town 1
Charlotte 1
Chongqing 1
Clifton 1
Columbus 1
Council Bluffs 1
Totale 3.470
Nome #
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 146
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 142
Meld-na and Survival Benefit In Liver Transplantation 117
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 116
"DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?" 115
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics 112
Liver Transplantation In Cirrhotic Patients With Meld Score < 18: A New Prognostic Model To Predict Drop-out From the Waiting List 111
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 107
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 106
De Novo Tumors after Liver Transplantation: Results from a Multicentric Study, Italy 1990-2008 105
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 104
Model for End-Stage Liver Disease-Sodium and Survival Benefit in Liver Transplantation. 99
Female gender in the setting of liver transplantation. 99
A Longitudinal, Prospective Study On Adherence To Medical Regimen Before and After Liver Transplantation 97
USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE 92
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 91
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 89
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 89
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 86
Who Fares Worse After Liver Transplantation? Impact of Donor and Recipient Variables on Outcome: Data from a Prospective Study. 83
Liver transplantation for viral hepatitis in 2015 83
Prioritization Tools To Predict Short and Long Term Mortality Following Liver Transplantation 82
A New Allocation Model For Liver Transplantation Combining Urgency Based Prioritization With Donor-recipient Matching: A Prospective Controlled Study 82
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study 82
Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis 82
Italian practical clinical guidelines on cholangiocarcinoma: Part II, Treatment 79
Does Once-Daily Tacrolimus (Advagraf) Increase Adherence to Immunosuppressive Therapy in Liver Transplanted Patients? 76
Estimation of the Harm To the Waiting List As Crucial Factor In the Selection of Patients With Hepatocellular Carcinoma For Liver Transplantation 75
A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS-CoV-2 infection 73
Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation 69
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection 67
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging 66
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 64
Extending transplantation criteria for hepatocellular carcinoma 64
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting 63
Self-Reported Adherence to Medical Prescriptions before and after Liver Transplantation: A Longitudinal Study 61
Management of portal hypertension severe complications 59
Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology 56
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 55
Host and virological features of HCV infection in liver transplant setting 55
Drug induced liver injury: from pathogenesis to liver transplantation 54
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 54
Prospective Evaluation of Long Term Cognitive and Neurological Alterations in Liver Transplanted Patients with Central Pontine (CPM) and Extrapontine Myelinolysis (EPM) 53
Incidence of De Novo Tumors after Liver Transplantation: Results from a Multicentric Study, Italy 1990-2009 52
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation 50
Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor 48
Reply 40
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 40
Impact of Donor-Recipient Risk Factors on Patient and Graft Survival after Liver Transplantation? A Single Centre Experience 39
Malnourished cirrhotic patient: what should we do? 38
Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy 34
New indications for liver transplantation 32
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool 30
Impact of Recipient MELD and Na plus , Donor Age on Short Patient Survival Following Liver Transplantation 28
Management of hepatocellular carcinoma recurrence after liver transplantation 28
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review 24
Invasive fungal infection before and after liver transplantation 24
Frailty and sarcopenia in patients with cirrhosis awaiting liver transplantation: evidence from a single-centre, prospective cohort study 23
Recent advances in the management of acute variceal hemorrhage 21
Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) 20
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation 19
Chest X-ray Interpretation: Detecting Devices and Device-Related Complications 14
Efficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role? 13
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept 12
Trends in liver transplantation for primary sclerosing cholangitis 11
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept 9
Evolution of Liver Transplantation Indications: Expanding Horizons 6
Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship 2
Totale 4.317
Categoria #
all - tutte 19.837
article - articoli 19.575
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020464 0 0 0 0 61 47 71 68 69 70 61 17
2020/2021559 32 31 38 30 35 14 29 43 77 95 41 94
2021/2022877 46 107 62 36 41 118 78 50 37 52 79 171
2022/2023613 103 72 20 76 100 81 12 39 56 3 45 6
2023/2024449 30 68 45 34 36 46 55 26 20 23 24 42
2024/2025501 5 139 96 89 172 0 0 0 0 0 0 0
Totale 4.317